Sign in

CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company

Adaptimmune Therapeutics PLC

Sign in to watch
Ticker
ADAPY
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
United Kingdom
Entity type
operating
Phone
44 1235 430000
Business address
60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
Former names
Adaptimmune Ltd
  1. 4 Open-market buy Director bought 15,000,000 shares at $1.67 ($25,000,500)
  2. 4 Open-market buy 10% owner bought 3,000,000 shares at $1.67 ($5,000,100)
  3. 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
  4. 4 Open-market buy Director bought 12,000,000 shares at $1.67 ($20,000,400)
  5. 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
  6. 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
  7. 4 Open-market buy 10% owner bought 3,000,000 shares at $1.67 ($5,000,100)
  8. 4 Open-market buy 10% owner bought 3,000,000 shares at $1.67 ($5,000,100)
  9. 8-K Event Other events
  10. 8-K Event Material agreement · Other events
  11. 424B5 Offering Prospectus
  12. CT ORDER Other Confidential Order
  13. 4 Open-market sale Chief Technology Officer sold 25,000 shares at $10.25 ($256,250)
  14. 8-K Event Other events
  15. 4 Derivatives Options or other derivatives
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Material agreement · Other events
  19. 8-K Event Other events
  20. S-3ASR Offering Registration Statement

Page 26 of 41 · 808 filings